
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $194.8M | -- | -- | $0.55 | -- |
07/31/2025 | Q2 | $193.6M | -- | -- | $0.53 | -- |
05/07/2025 | Q1 | $186.5M | $189.7M | $0.07 | $0.48 | -$0.41 |
02/12/2025 | Q4 | $180M | $183M | -- | $0.47 | -- |
11/06/2024 | Q3 | $173.5M | $175M | -$0.20 | $0.36 | -$0.56 |
07/31/2024 | Q2 | $171M | $172.9M | -$0.22 | $0.32 | -$0.54 |
05/01/2024 | Q1 | $163.4M | $165.5M | -$0.23 | $0.28 | -$0.51 |
02/21/2024 | Q4 | $161.5M | $162.1M | -$0.31 | $0.26 | -$0.57 |
11/01/2023 | Q3 | -- | -- | -$0.40 | $0.19 | -$0.59 |
08/02/2023 | Q2 | -- | -- | -$0.41 | $0.13 | -$0.54 |
05/09/2023 | Q1 | -- | -- | -$0.01 | $0.08 | -$0.09 |
02/21/2023 | Q4 | -- | -- | -$0.56 | $0.12 | -$0.68 |
11/07/2022 | Q3 | -- | -- | -$0.48 | $0.04 | -$0.52 |
08/03/2022 | Q2 | -- | -- | -$0.44 | $0.05 | -$0.49 |
05/02/2022 | Q1 | -- | -- | -$0.41 | $0.06 | -$0.47 |
02/15/2022 | Q4 | -- | -- | -$0.45 | $0.05 | -$0.50 |
11/03/2021 | Q3 | -- | -- | -$0.56 | $0.04 | -$0.60 |
08/04/2021 | Q2 | -- | -- | -$0.53 | $0.08 | -$0.61 |
05/05/2021 | Q1 | -- | -- | -$0.46 | $0.08 | -$0.54 |
02/17/2021 | Q4 | -- | -- | -$0.69 | $0.05 | -$0.74 |
11/04/2020 | Q3 | -- | -- | -$0.50 | $0.06 | -$0.56 |
08/05/2020 | Q2 | -- | -- | -$0.76 | -$0.02 | -$0.74 |
05/06/2020 | Q1 | -- | -- | -$0.70 | -$0.12 | -$0.58 |
02/19/2020 | Q4 | -- | -- | -$0.32 | $0.10 | -$0.42 |
11/06/2019 | Q3 | -- | -- | -$0.39 | $0.03 | -$0.42 |
08/07/2019 | Q2 | -- | -- | $0.01 | -$0.02 | $0.03 |
05/07/2019 | Q1 | -- | -- | -$0.05 | -$0.04 | -$0.01 |
02/13/2019 | Q4 | -- | -- | $0.08 | -$0.02 | $0.10 |
11/06/2018 | Q3 | -- | -- | $0.09 | $0.01 | $0.08 |
08/07/2018 | Q2 | -- | -- | $0.01 | $0.01 | $0.00 |
05/02/2018 | Q1 | -- | -- | $0.04 | -$0.02 | $0.06 |
02/14/2018 | Q4 | -- | -- | $0.05 | $0.01 | $0.04 |
11/01/2017 | Q3 | -- | -- | $0.03 | -$0.02 | $0.05 |
08/03/2017 | Q2 | -- | -- | -$0.03 | -$0.06 | $0.03 |
05/08/2017 | Q1 | -- | -- | -$0.03 | -$0.06 | $0.03 |
02/15/2017 | Q4 | -- | -- | -$0.03 | -$0.04 | $0.02 |
11/03/2016 | Q3 | -- | -- | -- | -- | -- |
08/03/2016 | Q2 | -- | -- | -- | -- | -- |
05/09/2016 | Q1 | -- | -- | -- | -- | -- |
02/10/2016 | Q4 | -- | -- | -- | -- | -- |
11/05/2015 | Q3 | -- | -- | -- | -- | -- |
Q2 Holdings reported $189.7M worth of top line sales in its most recent quarter.
Q2 Holdings announced earnings per share of $0.07 which represents a miss of analyst forecast a $0.48 per share.
Q2 Holdings reported $101M that represents $1.56 per share over the last quarter.
Q2 Holdings's earnings are forecast to grow from -$0.64 per share to $1.61 per share next year representing an increase of --.
Q2 Holdings's next earnings date is July 31, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.